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ABSTRACT The invasion-associated type III secretion system (T3SS-1) of Salmonella enterica serotype Typhimurium (S. Typhi-
murium)activatesthetranscriptionfactorNF-Bintissueculturecellsandinducesinﬂammatoryresponsesinanimalmodels
throughunknownmechanisms.HereweshowthatbacterialdeliveryorectopicexpressionofSipA,aT3SS-1-translocatedpro-
tein,ledtotheactivationoftheNOD1/NOD2signalingpathwayandconsequentRIP2-mediatedinductionofNF-B-dependent
inﬂammatory responses. SipA-mediated activation of NOD1/NOD2 signaling was independent of bacterial invasion in vitro but
requiredanintactT3SS-1.Inthemousecolitismodel,SipAtriggeredmucosalinﬂammationinwild-typemicebutnotinNOD1/
NOD2-deﬁcientmice.TheseﬁndingsimplicateSipA-drivenactivationoftheNOD1/NOD2signalingpathwayasamechanism
by which the T3SS-1 induces inﬂammatory responses in vitro and in vivo.
IMPORTANCE Salmonella enterica serotype Typhimurium (S. Typhimurium) deploys a type III secretion system (T3SS-1) to in-
duceintestinalinﬂammationandbeneﬁtsfromtheensuinghostresponse,whichenhancesgrowthofthepathogenintheintesti-
nallumen.However,themechanismsbywhichtheT3SS-1triggersinﬂammatoryresponseshavenotbeenresolved.Herewe
showthattheT3SS-1effectorproteinSipAinducesNF-BactivationandintestinalinﬂammationbyactivatingtheNOD1/
NOD2signalingpathway.ThesedatasuggestthattheT3SS-1escalatesinnateresponsesthroughaSipA-mediatedactivationof
patternrecognitionreceptorsinthehostcellcytosol.
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T
he principal pathogenic strategy of Salmonella enterica sero-
type Typhimurium (S. Typhimurium) is to use its virulence
factorstoelicitacuteintestinalinﬂammation(1).Aby-productof
this host response is the generation of a new respiratory electron
acceptor, tetrathionate, which enables the pathogen to outgrow
other microbes in the intestinal lumen (2), thereby enhancing its
transmission(3).S.TyphimuriumutilizesatypeIIIsecretionsys-
tem (T3SS-1) encoded by Salmonella pathogenicity island 1 (SPI
1) to elicit intestinal inﬂammation in animal models (1, 4). The
principal function of the T3SS-1 is to deliver proteins, termed
effectors,intohostcells(5,6).FiveT3SS-1effectors,termedSipA,
SopA,SopB,SopD,andSopE2,actinconcerttotriggeralterations
intheactincytoskeletonofhostcells,therebypromotingepithelial
invasion (7–11) and intestinal inﬂammation (12). S. Typhimu-
rium induces activation of mitogen-activated protein (MAP) ki-
nases, activation of nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-B), and production of proinﬂammatory
cytokines in cultured cell lines in a T3SS-1-dependent fashion
(13), suggesting that cytosolic access by the T3SS-1 triggers host
cell responses.
Several mechanisms through which cytosolic access by the
T3SS-1 can induce inﬂammatory responses have been proposed.
These mechanisms have in common that cytosolic access by the
T3SS-1 is detected by host macrophages via cytosolic recognition
oftranslocatedbacterialproteins,resultingincaspase1activation
and consequent proteolytic activation of interleukin-1 (IL-1)
andIL-18,twoproinﬂammatorycytokines(14–16).However,itis
also clear that these mechanisms are not sufﬁcient to explain im-
portant in vitro and in vivo observations, suggesting that addi-
tional pathways by which the T3SS-1 induces inﬂammatory re-
sponsesremaintobediscovered.Speciﬁcally,activationofcaspase
1 cannot account for the T3SS-1-dependent activation of NF-B
observed in vitro (13). Furthermore, the invasion-associated
T3SS-1 of S. Typhimurium elicits intestinal inﬂammation in vivo
through a myeloid differentiation primary response protein 88
(MyD88)-independent mechanism (17). Caspase 1 activation
does not explain the generation of these MyD88-independent
proinﬂammatory responses, because MyD88 is required for sig-
naling through receptors for IL-1 and IL-18 (18–20). Here we
identify a new MyD88-independent mechanism by which the
T3SS-1 induces host cell responses in vitro and demonstrate that
this mechanism contributes to S. Typhimurium-induced intesti-
nal inﬂammation in vivo.
RESULTS
NF-B activation by the invasion-associated T3SS is invasion
independent. The invasion-associated T3SS-1 of S. Typhimu-
riumactivatesNF-Binhumanepithelialcells(seeFig.S1Ainthe
supplemental material) (13, 21). To analyze whether this process
is invasion dependent, we used human epithelial cells transfected
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S. Typhimurium mutant (invA mutant) neither activated NF-B
(Fig. 1A) nor invaded epithelial HeLa cells (Fig. S1B). Introduc-
tion of the Yersinia pseudotuberculosis invasin protein (22) in-
creasedinvasivenessoftheT3SS-1-deﬁcientS.Typhimuriummu-
tant (P  0.05) but did not restore NF-B activation. Similar
results were obtained with human embryonic kidney 293
(HEK293) cells, although inactivation of the invasion-associated
T3SS resulted only in a partial inhibition of NF-B activation in
this cell line (Fig. S1C and S1D).
The T3SS-1 effectors SipA, SopA, SopB, SopD, and SopE2 act
in concert to promote invasion of epithelial cells (10). An S. Ty-
phimurium mutant lacking these ﬁve effector proteins (sipA sop-
ABDE2 mutant) was deﬁcient for invasion (P  0.05) and NF-B
activation (P  0.05) (see Fig. S1 in the supplemental material).
Introduction of the Y. pseudotuberculosis invasin protein into the
sipA sopABDE2 mutant restored invasiveness (P  0.05) but not
NF-Bactivation.ThesedatasuggestedthatNF-Bactivationre-
quired delivery of T3SS-1 effector proteins but not bacterial inva-
sion.
SipAisakeymediatorofNF-Bactivationinvitro.Todeter-
mine whether host cells can sense delivery of speciﬁc effectors, we
complemented the S. Typhimurium sipA sopABDE2 mutant with
plasmids encoding SipA, SopA, SopB, SopD, or SopE2 (10) and
monitored NF-B activation (Fig. 1). Only a plasmid encoding
SipA complemented the sipA sopABDE2 mutant for NF-B acti-
vation in epithelial HeLa cells (P  0.05) (Fig. 1A). Endogenous
TLR5 expression renders HEK293 cells responsive to stimulation
with ﬂagellin (23, 24), which might explain why we observed
NF-BactivationinresponsetoinfectionwiththesipAsopABDE2
mutant or to stimulation with puriﬁed S. Typhimurium ﬂagellin
(FliC)(P0.05)inthiscellline(Fig.1Aand1B).Consistentwith
FIG 1 SipA-mediated activation of NF-B in HeLa and HEK293 cells is MyD88 independent. (A) HeLa cells (gray bars) and HEK293 cells (black bars)
transfectedwithanNF-BluciferasereporterconstructwereinfectedwiththeS.TyphimuriumsipAsopABDE2mutantcomplementedwithgenesencodingthe
indicatedeffectorproteins.(B)HEK293cellsweretransfectedwithMyD88DNandinfectedwiththeS.TyphimuriumsipAsopABDE2mutantandcomplemented
derivatives. Data represent the NF-B luciferase activity as fold increase over the uninfected controls. Values are the means from at least 3 independent
experiments  standard errors. Brackets indicate the statistical signiﬁcance of differences. NS, not signiﬁcant.
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dominant-negative form of the TLR5 adaptor protein MyD88
(MyD88DN) abrogated NF-B activation induced by the sipA
sopABDE2 mutant or puriﬁed ﬂagellin (Fig. 1B). Complementa-
tion of the sipA sopABDE2 mutant with plasmids encoding SipA
or SopE2 induced NF-B activation in HEK293 cells transfected
withMyD88DN(P0.05)(Fig.1B).Collectively,thesedatasug-
gested that bacterial delivery of SipA activates NF-B through a
MyD88-independent mechanism.
To determine whether SipA is sufﬁcient for NF-B activation,
a green ﬂuorescent protein (GFP)-SipA fusion protein was ex-
pressed ectopically in HEK293 cells transfected with an NF-B
luciferase reporter construct (Fig. 2). Ectopic expression of GFP-
SipA, but not ectopic expression of GFP, resulted in NF-B acti-
vation(P0.05).Thesedatasuggestedthatcytosoliclocalization
of SipA in the absence of other bacterial molecules was sufﬁcient
for inducing NF-B activation in host cells.
TheSipAproteincontainsanN-terminaldomainrequiredfor
T3SS-1 translocation (NTD), a C-terminal actin-binding domain
(ABD),andtwocentraldomainsmediatingSipAfocusformation
(F1) and SipA-SipA interaction (F2) (25). GFP-SipA fusion pro-
teins lacking one or several of these domains were constructed to
investigate which domain(s) is required for NF-B activation
(Fig. 2A). Ectopic expression of these fusion proteins in HEK293
cells suggested that the F2 domain, which is not required for host
cell invasion (25), was necessary but not sufﬁcient for NF-B ac-
tivation (P  0.05) (Fig. 2B; see also Fig. S2 in the supplemental
material). In contrast, the ABD, which is required to support
S. Typhimurium host cell invasion (25), was not necessary for
NF-B activation.
TodeterminewhethertheF2domainwasnecessaryforNF-B
activation upon bacterial delivery of SipA, we complemented the
sipA sopABDE2 mutant with plasmids carrying truncated sipA
genes encoding the ﬁrst 425 amino acids (aa) (sipA’1-425), the
FIG 2 The F2 domain of SipA is necessary but not sufﬁcient for NF-B activation. (A) Schematic representation of the SipA domain structure (top). The
compositionofGFP-SipAfusionproteinsisindicatedbelow.(B)HEK293cellswerecotransfectedwithanNF-Bluciferasereporterconstructandtheindicated
GFP-SipA fusion proteins. At 48 hours after transfection, cells were lysed to measure luciferase activity. Data represent the means  standard errors of at least
three independent experiments.
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(sipA’1-149) of SipA. Complementation of the sipA sopABDE2
mutant with genes encoding full-length SipA or a truncated SipA
lacking the ABD (sipA’1-425) resulted in NF-B activation
through a MyD88-independent mechanism (Fig. 3). In contrast,
NF-B activation was not observed with proteins lacking the F2
domain, which were encoded by sipA’1-290 and sipA’1-149. In
summary, the F2 domain was necessary for NF-B activation re-
gardless of whether SipA was delivered by bacteria or expressed
ectopically.
SipA-mediatedNF-BactivationrequiresRIP2invitro.One
MyD88-independent mechanism contributing to intestinal in-
ﬂammation during S. Typhimurium infection is the activation of
nucleotide-binding and oligomerization domain 1 (NOD1) and
NOD2, two intracellular sensors of bacterial cell wall fragments
(26, 27). NOD1 and NOD2 interact with protein kinase receptor-
interactingprotein2(RIP2)tomediateNF-Bactivation(28,29).
Stimulation of HEK293 cells with the NOD1 ligand C12-iE-DAP
resulted in NF-B activation (P  0.05), which was MyD88 inde-
pendent and could be inhibited with SB203580 (Fig. 3B and 3D),
a pyridinyl imidazole inhibitor of RIP2 activity (30). NF-B acti-
vation induced by bacterial delivery of SipA was abrogated when
cells were treated with the RIP2 inhibitor SB203580 (Fig. 3A and
3C). These data suggested that SipA-mediated NF-B activation
required RIP2.
SipA-mediated NF-B activation requires both NOD1 and
NOD2 in vitro. We next investigated whether NOD1 or NOD2
was required for SipA-dependent NF-B activation (Fig. 4).
FIG 3 The RIP2 inhibitor SB203580 inhibits SipA-mediated NF-B activation. HEK293 cells were transfected with an NF-B luciferase reporter construct (A
andB)andMyD88DN(CandD).ThirtyminutesbeforeinfectionofthecellswiththeindicatedS.Typhimuriumstrains,thecellswerepretreatedwithdimethyl
sulfoxide (black bars) or with 10 M SB203580 (white bars). After 5 h, the cells were lysed and luciferase activity was measured. Data represent the means 
standard errors of at least three independent experiments. Brackets indicate the statistically signiﬁcant differences. *, P  0.05. NS, not signiﬁcant.
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dominant-negative NOD1 protein (Nod1DN) or a dominant-
negative RIP2 protein (Rip2DN) inhibited NF-B activation elic-
ited by stimulation with the NOD1 ligand C12-iE-DAP (Fig. 4A).
Similarly, transfection of HEK293 cells with dominant-negative
NOD2(Nod2DN)orRip2DNinhibitedNF-Bactivationelicited
FIG 4 SipA-mediated NF-B activation requires both NOD1 and NOD2 in vitro. (A to C) HEK293 cells were transfected with the NF-B luciferase reporter
constructandhNOD1DN,hNOD2DN,hRIP2DN,orvectoronlyandstimulatedwith1g/mlC12-iE-DAP(NOD1ligand)(A),10g/mlMDP(NOD2ligand)
(B), and 100 ng/ml puriﬁed ﬂagellin (C). (D and E) HEK293 cells were cotransfected with the NF-B luciferase reporter construct and GFP-SipA (D) or
GFP-SipA425(E)andhNOD1DN,hNOD2DN,hRIP2DN,orvectoronly.DataareexpressedaspercentNF-Binhibition,where100%wassettobetheresponse
inthecellstransfectedwithvectoronly.Valuesrepresentthemeansstandarderrorsofatleastthreeindependentexperiments.Bracketsindicatethestatistical
differences.NS,notsigniﬁcant.(F)WesternblotanalysisofHEK293cellsexpressingGFP-taggedSipA425andFlag-taggedhNOD1DN,Flag-taggedhNOD2DN,
HA-tagged hRIP2DN, or vector only. Cotransfection did not inﬂuence the expression of GFP-SipA425.
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(Fig.4B).Dominant-negativeformsofNOD1(Nod1DN),NOD2
(Nod2DN), or RIP2 (Rip2DN) did not inhibit NF-B activation
in HEK293 cells stimulated with ﬂagellin (FliC) (Fig. 4C). Impor-
tantly, transfection of HEK293 cells with dominant-negative
forms of NOD1 (Nod1DN), NOD2 (Nod2DN), or RIP2
(Rip2DN) inhibited NF-B activation elicited by ectopic expres-
sion of GFP-SipA or GFP-SipA425 (P  0.05) (Fig. 4D and 4E).
Cotransfectionofthedominant-negativeformsofNOD1,NOD2,
or RIP2 with GFP-SipA425 did not markedly affect protein ex-
pression of SipA425 (Fig. 4F). Ectopic expression excluded the
possibility that SipA-mediated NF-B activation was due to con-
taminationwithendogenousbacterialligands,suchasMDP.Fur-
thermore, both NOD1 and NOD2 contributed to NF-B activa-
tion in response to ectopic expression of SipA (Fig. 4D), while
responses to C12-iE-DAP required only NOD1 (Fig. 4A) and re-
sponsestoMDPrequiredonlyNOD2(Fig.4B).Collectively,these
data suggested that SipA activated NOD1/NOD2 through a path-
way that was distinct from that observed with bacterial cell wall
fragments.
To investigate interaction of SipA with NOD1, HEK293 cells
were transfected with Flag-tagged NOD1 protein (NOD1-Flag)
andeitherMyc-taggedSipAprotein(Myc-SipA)orGFP-SipA425.
After immunoprecipitation of Flag-NOD1 with anti-Flag anti-
body, SipA was detected in the immunoprecipitate (Fig. 5). Fur-
thermore, colocalization of SipA and NOD1 was observed micro-
scopicallyinsomeHEK293cellstransfectedwithNOD1-Flagand
GFP-SipA(seeFig.S3inthesupplementalmaterial).Collectively,
thesedatasuggestedthatSipAeitherinteractswithNOD1directly
or is present in a protein complex that contains NOD1.
SipA does not trigger mucosal inﬂammation in NOD1/
NOD2-deﬁcient mice. To test the biological signiﬁcance of our
observations, we determined the role of NOD1/NOD2 in SipA-
mediated inﬂammation in vivo using the mouse colitis model of
S. Typhimurium infection (4). The T3SS effectors SipA, SopA,
SopB,SopD,andSopE2actinconcerttotriggerintestinalinﬂam-
FIG 5 Coimmunoprecipitation of NOD1 and SipA. At 48 hours after transfection of HEK293 cells with the indicated constructs, immunoprecipitation was
performed using anti-Flag antibodies. Proteins were detected in whole-cell lysates and immunoprecipitates by Western blot analysis with anti-Flag antibody
(-Flag), anti-Myc antibody (-myc), or anti-GFP antibody (-GFP).
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nisms of inﬂammation, we compared an S. Typhimurium strain
producing only SipA (sopABDE2 mutant) with an isogenic SipA-
deﬁcient mutant (sipA sopABDE2 mutant). Remarkably, the
SipA-proﬁcient S. Typhimurium strain (sopABDE2 mutant) trig-
geredmucosalinﬂammationinwild-typemice(C57BL/6)butnot
in the NOD1/NOD2-deﬁcient mice 2 days after infection (Fig. 6;
see also Fig. S4 in the supplemental material). NOD1/NOD2-
deﬁcientmicefailedtoinduceSipA-dependentexpressionofIfng,
thegeneencodinggammainterferon(IFN-)(Fig.6A),andTnfa,
thegeneencodingtumornecrosisfactoralpha(TNF-)(Fig.6B),
in the cecal mucosa. Wild-type (C57BL/6) mice infected with the
SipA-proﬁcient S. Typhimurium strain (sopABDE2 mutant) ex-
hibited marked intestinal inﬂammation, which was absent in
wild-typemiceinfectedwiththeSipA-deﬁcientmutant(sipAsop-
ABDE2 mutant) or in NOD1/NOD2-deﬁcient mice (Fig. 6C; see
also Fig. S4). In summary, a SipA-proﬁcient S. Typhimurium
FIG6 Inﬂammatoryresponsesinthemousecolitismodel.C57BL/6mice(wildtype,blackbars)andNOD1/NOD2-deﬁcientmice(whitebars)wereinoculated
with the S. Typhimurium sopABDE2 mutant, the S. Typhimurium sipA sopABDE2 mutant, or sterile medium (mock infected), and cecal tissue was collected at
48hoursafterinfection.(AandB)RelativeIfng(A)andTnfa(B)transcriptlevelsinthececaltissueweredeterminedbyquantitativereal-timePCR.Barsrepresent
the geometric means  standard errors from eight different animals. Brackets indicate the statistical signiﬁcance of differences. NS, not signiﬁcant. (C)
Histopathological analysis of the cecal mucosa. Boxes in whisker plots represent the second and third quartiles of combined histopathology scores, while lines
indicate the ﬁrst and fourth quartiles. Brackets indicate the statistical signiﬁcance of differences. NS, not signiﬁcant.
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tion.
DISCUSSION
ThetranslocationofmultipleproteinsbytheT3SS-1canmaskthe
contribution of an individual pathway to inﬂammation in vivo.
For example, previous studies show that S. Typhimurium can in-
duceinﬂammationinmicedeﬁcientforMyD88,RIP2,orcaspase
1(31).However,whenmiceareinfectedwithanS.Typhimurium
strain translocating only the SopE protein (sipA sopB sopE2 sseD
mutant), it becomes apparent that caspase 1 activation contrib-
utes to mucosal inﬂammation in the mouse colitis model (32).
Similarly, here we show that a contribution of NOD1/NOD2 sig-
nalingtoinﬂammationisapparentwhenmiceareinfectedwithan
S. Typhimurium strain that translocates SipA but carries muta-
tionsingenesencodingotherT3SS-1effectorproteinsinvolvedin
eliciting intestinal inﬂammation.
SipA is a protein delivered into the host cell cytosol by the
invasion-associated T3SS of S. Typhimurium (6). SipA contrib-
utes to invasion of epithelial cell lines by modulating actin assem-
bly through its C-terminal ABD (6, 9–11, 25). The N-terminal
425 amino acids of SipA trigger neutrophil transepithelial migra-
tion in vitro (33–36). Finally, SipA contributes to intestinal in-
ﬂammation in vivo (12, 37), but the underlying mechanism has
remainedunclear.Hereweshowthattheproinﬂammatoryeffects
of SipA required NOD1/NOD2 activity. Furthermore, in vitro ex-
periments demonstrated that SipA was necessary and sufﬁcient
forNOD1/NOD2-dependentNF-Bactivation,aprocessthatdid
notrequireitsABD.Thesedatasuggestedthatcytosolicsensingof
SipA by the pattern recognition receptors NOD1 and NOD2
served as a signal for cytosolic access by the invasion-associated
T3SS-1 of S. Typhimurium, thereby escalating mucosal inﬂam-
matory responses. Consistent with this idea, SipA enhanced mu-
cosalinﬂammationinthemousecolitismodelinaNOD1/NOD2-
dependent fashion.
MATERIALS AND METHODS
Bacterial strains, tissue culture cells, and culture conditions. S. Typhi-
murium strain IR715 (38), a fully virulent, nalidixic acid-resistant deriv-
ative of American Type Culture Collection (ATCC) isolate 14028, was
used as a wild-type isolate. IR715 derivatives carrying mutations in invA
(SPN449) (39); in sopA, sopB, sopD, and sopE2 (ZA20) (12); and in sipA,
sopA, sopB, sopD, and sopE2 (ZA21) (12) have been described previously.
Plasmids carrying the sopD gene (pMR15), the sopE2 gene (pMR17), the
sopB gene (pMR26), the sopA gene (pMR28), or the sipA gene (pMR29)
from S. Typhimurium have been described previously (10). The sipA425,
sipA290, and sipA149 fragments of the sipA gene were ampliﬁed without
the sipA promoter from pMR29 and cloned directionally behind the lac
promoterofcloningvectorpWSK29(40)withBamHIandXbaI.Plasmid
pRI203, encoding the Yersinia pseudotuberculosis invasin protein, has
beendescribedpreviously(22).Bacteriaweregrownaerobicallyat37°Cin
Luria-Bertani (LB) broth supplemented with antibiotics. The HeLa 57A
cell line stably transfected with an NF-B luciferase reporter construct
(41) was generously provided by R. T. Hay (the Wellcome Trust Centre
for Gene Regulation and Expression, College of Life Sciences, University
of Dundee, United Kingdom). The HEK293 cell line was purchased from
ATCC. HeLa 57A cells and HEK293 cells were maintained in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) containing 10% fetal calf serum
(FCS) at 37°C in a 5% CO2 atmosphere.
Constructionofexpressionplasmids.ThesipAgenewasPCRampli-
ﬁed from the chromosome of S. Typhimurium IR715, and the obtained
product was cloned into the mammalian expression vector pEGFP-C1
(BD Biosciences Clontech). The mutant forms of sipA were PCR ampli-
ﬁedfrompEGFP-SipAandclonedinpEGFP-C1.Expressionvectorswith
deletions in the F1 domain (pEGFP-F1ABD) and in the F2 domain
(pEGFP-F2) were engineered by overlap extension PCR. The two DNA
fragments needed for the construction of these sipA mutant forms were
ampliﬁedbyPCR,gelpuriﬁed,andfusedinonePCR.Thefull-lengthsipA
and the mutant forms were expressed as a fusion to the C terminus of the
enhancedGFP(EGFP).ConstructionofMyc-SipAwasobtainedbyclon-
ingthefull-lengthsipAgeneratedbyPCRfrompEGFP-SipAintopCMV-
myc (Clontech). The full-length human NOD1 and dominant-negative
versions of human NOD1 (hNOD1) and hNOD2 were PCR ampliﬁed
from pUNO-hNOD1 and pUNO-hNOD2 (InvivoGen), respectively.
hNOD1DN (amino acids [aa] 127 to 954) lacks the N-terminal caspase
recruitment domain (CARD). hNOD2DN (aa 217 to 1041) lacks the two
N-terminal CARDs. The obtained PCR products were cloned into a de-
rivativeofthemammalianexpressionvectorpTracer-CMV2(Invitrogen,
Life Technologies). The derivative lacks the GFP gene and contains a
3FlagtagattheC-terminalcloningsite(42).ThehumanRIP2genewas
PCR ampliﬁed from cDNA prepared from HEK293 cells. The obtained
PCR product was cloned into pTracer-CMV2, yielding pTracer-hRIP2
(aa1to540).Thedominant-negativeformofhRIP2(aa1to434),lacking
the C-terminal CARD, was PCR ampliﬁed from pTracer-hRIP2 and
cloned into pCMV-HA (Clontech). The hemagglutinin (HA) tag is fused
totheNterminusofhRIP2DN.TheplasmidpDeNy-MyD88expressinga
dominant-negative human MyD88 gene was purchased from InvivoGen.
All constructs were veriﬁed by DNA sequencing.
Gentamicin protection assay. HEK293 and HeLa 57A cells were
seeded in a 24-well tissue culture plate at approximately 50% conﬂuence.
Atthetimeofinfection,thecellshadaconﬂuenceofapproximately100%.
Overnight cultures of S. Typhimurium strains were diluted 1 in 50 and
grown for3ha t37°C. HEK293 and HeLa 57A cells were infected with
S. Typhimurium strains at approximately 107 CFU/ml. The bacteria were
incubated for1ha t37°C to allow invasion. The cells were washed three
times with Dulbecco’s phosphate-buffered saline (DPBS; pH 7.4) to re-
moveextracellularbacteria,DMEMcontaining10%FCSandgentamicin
(0.1 mg/ml) was added, and the cells were incubated for 90 min at 37°C.
ThecellswerewashedinDPBSandlysedwith0.5mlof1%TritonX-100,
andthelysatesweretransferredtoasterileEppendorftube.Thewellswere
washed with 0.5 ml PBS and transferred to the Eppendorf tubes. Serial
dilutions were plated on LB plates with the appropriate antibiotics to
count the intracellular bacteria.
Transient transfection. HEK293 cells were grown in 24- or 48-well
tissuecultureplatesinDMEMcontaining10%FCSuntil40%conﬂuence
was reached (~24 h). HEK293 cells were transiently transfected with a
totalof250ngofplasmidDNA,consistingof25ngofthereporterplasmid
pNF-B-luc, 25 ng of normalization vector pTK-LacZ, and 200 ng of
either empty control vector, pUNO-hMyD88DN (InvivoGen), or
pEGFP-SipAconstructs.ForthecotransfectionexperimentswithpEGFP-
SipA constructs and hNOD1DN-3Flag, hNOD1DN-3Flag, or HA-
hRIP2DN, 100 ng of DNA for each plasmid was used. FuGene HD
(Roche)wasusedastransfectionreagentatalipid-to-DNAratioof5to1.
After 48 h of incubation, the cells were infected with the appropriate
bacterial strains or the NOD1 ligand C12-iE-DAP, the NOD2 ligand
MDP, or the TLR5 ligand ﬂagellin (InvivoGen).
Luciferase assays. NF-B activation was assessed using the NF-B--
luciferase reporter system. HeLa 57A cells stably transfected with an NF-
B--luciferase reporter construct and transiently transfected HEK293
cells were infected with the indicated S. Typhimurium strains (107 CFU/
ml)for3h,afterwhichthecellswerewashedwithDPBSandincubatedat
37°Cforanadditional2hinthepresenceofDMEMcontaining10%FCS.
The cells were washed in DPBS and lysed in 0.1 ml of reporter lysis buffer
(Promega). Fireﬂy luciferase activity was measured with the luciferase
assay system (Promega) using a plate reader. For normalization of the
efﬁciency of transfection, luciferase values were adjusted to
-galactosidasevaluesasdeterminedwiththe-galactosidaseassay(Pro-
Keestra et al.
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Protein expression analysis. HEK293 cells transfected with fusion
proteins were lysed in lysis buffer (50 mM Tris-HCl, pH 7.6, 150 mM
NaCl, 0.2% [vol/vol] NP-40, and 1 mM EDTA). An 0.01-mg amount of
total protein was separated by SDS-polyacrylamide gel electrophoresis.
Proteins were transferred to a polyvinylidene ﬂuoride membrane (Milli-
pore) in a semidry transfer process (Bio-Rad). The membranes were in-
cubated in PBS containing 3% nonfat dry milk and 0.05% Tween 20 to
block nonspeciﬁc binding. The membranes were incubated with poly-
clonal primary antibodies raised against tubulin (Cell Signaling Technol-
ogy), mouse anti-Flag (Sigma), or mouse anti-HA (Covance). For GFP
detection, a horseradish peroxidase (HRP)-conjugated anti-GFP anti-
body(CellSignalingTechnology)wasused.HRP-conjugatedanti-mouse
IgG and HRP-conjugated anti-rabbit IgG (Promega) were used as the
secondary antibodies for tubulin, Flag, and HA detection. Horseradish
peroxidase activity was visualized by adding Immobilon Western chemi-
luminescent substrate (Millipore) to the membrane. Images were re-
corded and processed by a BioSpectrum imaging system (UVP).
Coimmunoprecipitation. HEK293 cells were transiently transfected
for 48 h and lysed with lysis buffer (50 mM Tris-HCl, pH 7.6, 150 mM
NaCl,0.1%[vol/vol]NP-40,1mMEDTA,andproteaseinhibitors).Sam-
ples of the whole-cell lysate were collected for analysis by SDS-PAGE and
immunoblotting. The whole-cell lysate was incubated for2ha t4 ° Cwith
Dynal protein G beads (Invitrogen) coated with anti-Flag M2 antibody
(Sigma). After 10 washes with the lysis buffer and 2 washes with 50 mM
ammonium bicarbonate, samples of the immunoprecipitate were col-
lected and subjected to SDS-PAGE and immunoblotting. The proteins of
interest were detected with anti-Flag M2 antibody (Sigma), anti-Myc an-
tibody (Cell Signaling), and anti-GFP antibody (Sigma).
Fluorescence microscopy. HEK293 cells were transfected with GFP-
SipAandNOD1-Flag.After48h,thecellswerewashedandﬁxedwith3%
paraformaldehyde.Thecellswerepermeabilizedwith0.1%saponin-10%
goat serum (blocking reagent) in PBS for 30 minutes at room tempera-
ture. After blocking, cells were incubated with anti-Flag M2 antibody
(1:1,000dilution;Sigma)in0.1%saponinand10%goatseruminPBSfor
1 h at room temperature. The cells were rinsed twice in 0.1% saponin in
PBS and then twice in PBS and incubated (1 h) with Alexa Fluor 647 goat
anti-mouse IgG (1:1,000 solution; Invitrogen). After the cells were rinsed
twice in 0.1% saponin in PBS, twice in PBS, and once in H2O, they were
embeddedinFluorsave(Calbiochem)andanalyzedwithanLSM700con-
focal microscope (Zeiss).
Animal experiments. Streptomycin (20 mg/mouse) (Sigma)-
pretreated C57BL/6 mice (Jackson Laboratory) and NOD1/NOD2-
deﬁcient mice (generously provided by D. Portnoy) were mock infected
with 0.1 ml of sterile LB broth or infected orally with 1  109 CFU (in
0.1mlofLBbroth)ofanS.TyphimuriumsopABDE2mutant(ZA20)ora
sipA sopABDE2 mutant (ZA21) carrying the plasmid pHP45 to confer
streptomycin resistance. At 48 h after infection, mice were sacriﬁced, and
samples of the cecum were snap-frozen in liquid nitrogen for isolation of
mRNA.
Histopathology. Formalin-ﬁxed, hematoxylin- and eosin-stained ce-
caltissuesectionswereblindedforevaluationbyaveterinarypathologist.
The following pathological changes were scored: (i) neutrophil inﬁltra-
tion, (ii) inﬁltration by mononuclear cells, (iii) submucosal edema, (iv)
epithelial damage, and (v) inﬂammatory exudate. The pathological
changes were scored on a scale from 0 to 4 as follows: 0, no changes; 1,
detectable; 2, mild; 3, moderate; 4, severe. Images were taken using an
Olympus BX41 microscope.
Real-time PCR. Samples of the cecum were collected, immediately
snap-frozen in liquid nitrogen, and stored at 80°C. RNA was extracted
using TriReagent (Molecular Research) according to the instructions of
the manufacturer. Reverse transcription was performed on 1 go f
DNase-treatedRNAwithTaqManreversetranscriptionreagent(Applied
Biosystems). For each real-time reaction, 4 l of cDNA was used. Real
time transcription-PCR (RT-PCR) was performed using Sybr green (Ap-
plied Biosystems) and an ABI 7900 RT-PCR machine (Applied Biosys-
tems). The fold change in mRNA levels was determined using the com-
parative threshold cycle (CT) method (Applied Biosystems). Target gene
transcriptionwasnormalizedtothelevelsofglyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA.
Statisticalanalysis.ApairedStudentttestwasusedtoconﬁrmstatis-
tical signiﬁcance in the tissue culture experiments. To determine statisti-
cal signiﬁcance of the relative mRNA transcription between treatment
groupsintheanimalexperiments,anunpairedStudentttestwasused.To
determine the statistically signiﬁcant differences in the total histopathol-
ogy scores, a Mann-Whitney U test was used. A two-tailed P value of
0.05 was taken to be signiﬁcant.
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